A cute kidney injury (AKI) is increasingly recognized as a cause of increased morbidity in critically ill children and adults, and damage to the kidney, a central mediator of homeostasis in the body, affects patient survival (1) (2) (3) (4) . AKI is now known to be an independent risk factor for mortality, and research pursues optimization of diagnosis, management, and outcome (5) . The list of putative causes of AKI in pediatrics is long (6) (Table 1) ; however, the true etiology is likely multifactorial, related to a combination of several factors, such as ischemia and reperfusion injury, disruption of renal vasomotor homeostasis, hypoxic and oxidative stress, and cytokine-driven effects. The kidney is central to numerous realtime homeostatic control mechanisms, including water balance, electrolyte handling, erythropoiesis, vascular tone, acidbase status, and regulation of normal glucose metabolism; however, AKI diagnosis is based on downstream readouts. The laboratory indicator, decreased glomerular filtration rate, factors in urine and plasma solute concentration and is the accepted reflection of nephron function. Calculations of glomerular filtration rate (Table 2) rely on serum creatinine and are often unreliable because of variability within age groups, gender, metabolic state, body composition, and excretion by the kidney itself (7) (8) (9) . Definitions of oliguria, the bedside indicator for AKI diagnosis, also are varied. Although clinicians have shown that sick kidneys affect morbidity independently and synergistically with multi-organ disease, study of the impact of kidney injury is limited by having to use these markers of failure. Also unfortunate is the mirrored variability between diagnosis and treatment, which is largely reactive and can differ from patient to patient (10, 11) .
AKI represents a serious burden to the pediatric patient population (12) . We focus this narrative review on evidencebased AKI research, highlighting disturbing epidemiologic trends for pediatric AKI, novel detection strategies, the role of AKI as an independent causative agent of injury, and available evidence-based data regarding management and outcomes. Much further research in basic science and in prospective trials is needed to improve outcome for pediatric patients with this significant affliction.
METHODS
An electronic search was performed in January 2010 using the PubMed, Ovid, MEDLINE, and Cochrane databases for the following search terms: acute kidney injury, renal ischemia, pediatrics, RIFLE (risk, injury, failure, loss, end stage), Acute Kidney Injury Network, epidemiology, renal replacement therapy, and outcomes. Inclusion criteria were adult and pediatric articles from 2000 to 2010 in the English language. All retrospective pediatric AKI studies performed from 2000 to 2010 were included. Additionally, heavily cited articles within our search results were considered for inclusion.
Altered Renal Perfusion. The kidneys receive a high percentage (20% to 25%) of the cardiac output at any moment. Aberrations in the intricate regulatory mechanism in place to maintain renal perfusion pressure (Table 3) lead to injury such as acute tubular necrosis (13) . Pediatric kidney transplant recipients of organs with increased ischemic times during harvest have increased rates of acute tubular necrosis (14) , as do patients with long crossclamp times during cardiopulmonary bypass (CPB) (15, 16) . Direct effects on renal blood flow in the microvasculature of the vasa recta occur in sickle cell disease, rhabdomyolysis, hemolytic uremic syndrome, and tumor lysis syndrome.
Vasomotor Nephropathy. AKI occurs by stress-mediated glomerular endothelial release of vasoactive substances, proteases, reactive oxygen species, and nitric oxide. For example, the factor XII plasma contact system, coagulation cascades, and complement pathways are activated in renal endothelium during CPB (17, 18) .
Sepsis and AKI. Sepsis causes AKI in up to 50% of cases (19, 20) . Although the precise mechanism remains unclear, a gamut of cytokines is implicated, as are circulating lymphocytes, T cells, and native kidney tubular epithelial and endothelial cells. Interestingly, septic AKI does not appear to be ischemiadependent, because it can occur in hyperdynamic renal blood flow (21) .
Aberrant Oxygen Homeostasis. A natural degradation in oxygen tension exists from the level of the renal artery to the counter-current mechanism in the vasa recta (Fig.) , making the kidney highly susceptible to both hypoxic and oxidative injury during ischemiareperfusion (22) . Experimental ischemia leads to renal dysoxia, a situation also seen in sepsis, in which renal cells are unable to utilize oxygen for energy, regardless of oxygen availability (23) .
Nephrotoxins and AKI. Nephrotoxic medications in the intensive care unit contribute to nearly 25% of AKI cases (3, 4) . Common offenders include aminoglycoside antibiotics, nonsteroidal anti-inflammatory agents, radioopaque contrast, and immunosuppressives such as calcineurin inhibitors (24, 25) .
Associated Syndromes. AKI is seen in conjunction with pulmonary, hepatic, and cardiac failure (26, 27) . The increased mortality reported with these dual-axis syndromes underscores the kidney's centrality to host survival. Although exact mechanisms are unknown, they all are almost certainly linked to aberrations in blood flow distribution and to endothelial activation (28 -30) .
Isolated AKI. In complex cases, isolated renal injury is difficult, if not impossible, to identify and without concomitant fluid overload or electrolyte mishandling it is not felt to be significant. However, laboratory evidence shows that isolated AKI affects remote organ homeostasis and host morbidity. A wide set of regulatory genes and inflammatory mediators are altered during isolated renal ischemia and can lead to increased pulmonary capillary permeability (31, 32) , decreased active fluid transport out of alveoli (33) , and T-cell trafficking in rats (34) . Left ventricular systolic performance is reduced (35) and blood-brain barrier permeability increases after renal ischemia (36) . In these experiments, distal changes were found before any overt signs of renal injury, highlighting a renal "distress" state during which a host may be primed to further injury. Further work aims to identify a phenotype to this distress state, its downstream ramifications, and whether it is reversible.
Epidemiology of AKI in the Intensive Care Unit
Diagnosis. A review of nearly 30 studies conducted over 25 yrs showed that no two studies used the same criteria to define AKI (37) . To amend this variability, the Acute Dialysis Quality Initiative group standardized the definition of AKI in 2002 using the RIFLE criteria, a mnemonic for three levels of severity, risk, injury, and failure, and two outcomes, loss and end-stage kidney disease (38) . Based on glomerular filtration rate, serum creatinine values, and urine output plotted against time of admission, RIFLE marks progressive degrees of injury in both intensive care unit and non-intensive care unit adult patients. In 2004, the Acute Kidney Injury Network devised strata that defined AKI based on time in relation to absolute creatinine increase, percentage increase, or documented oliguria, broadening the window for time of AKI diagnosis and creating an automatic "failure" designation for any patient administered renal replacement therapy (39) . Although Acute Kidney Injury Network criteria have shown close approximations to RIFLE stratifications of patients (40, 41) , both schemes 
Eq, equation; GFR, glomerular filtration rate; S Cr , serum creatinine. Angiotensin inhibition equate specific changes in serum creatinine to specific worsening of oliguria, an assumption yet to be prospectively proven. Incidence and Outcome. Within the new strata (Table 4) , it is clear that the incidence of AKI is considerable in adults and children and outcomes can be severe. Increases in RIFLE and Acute Kidney Injury Network criteria correlate with increased morbidity.
Adults. Before the validation of the new classification schemes, reported incidence in adults varied from 7% to 25% (42, 43) . Hoste et al (44) now report that 18% to 63% of all adult hospitalized patients have some degree of AKI, up to 67% for intensive care patients, which increases mortality in sepsis, trauma, burn, transplantation, and acute respiratory distress syndrome, is an independent risk factor for mortality (with odds ratios as high as 4.8), and independently increases hospital costs, length of stay, and ventilator days. The incidence of AKI after CPB in adults ranges from 30% to 50% and increases mortality to nearly 80% in some reports (45, 46) . AKI also leads to end-stage renal disease in a significant portion of adults (47) .
Pediatrics. The reported incidence of AKI in pediatric populations varies from 1% to 82% (Table 5) , with a recent study finding an incidence of 339 of 3,396 (Ϸ10%) patients admitted to the pediatric intensive care unit (48) . Using a modification of the RIFLE criteria (pediatric RIFLE), approximately 50% of pediatric patients studied had some degree of kidney injury early in their hospital stay (mean time to pediatric RIFLE stratum, 3.3 Ϯ 3.1 days; 82% diagnosed within 7 days) (49) . In a study of nearly 4,000 critically ill children, AKI increased mortality and lengthened intensive care stay four-fold (48) . AKI increases mortality with multi-organ failure, marrow or solid organ transplantation, extracorporeal membrane oxygenation, or acute respiratory distress syndrome from 10% to 57.1% (12, 50 -51) . AKI has a high risk of death independent of Pediatric Risk of Mortality II scores in these patients (49) . AKI affects between 2.7% and 28% of children after CPB and has a notable increased morbidity risk, including longer duration of ventilation and overall length of stay (52, 53) . For these children, even a small creatinine increase of Ն25% is a high risk factor for AKI (54) . Finally, at 3-to 5-yr follow-up, 40% to 50% of pediatric patients who had AKI show signs of chronic renal insufficiency, indicating that sublethal injury permanently alters the renal bed (55) .
Biomarkers. RIFLE, pediatric RIFLE, and Acute Kidney Injury Network criteria have limited real-time/pre-injury utility because they rely on creatinine and urine output. Accordingly, the search is on for a real-time markers of AKI that would allow for rapid and reliable diagnosis, theoretically providing a therapeutic advantage to intensivists akin to troponins in myocardial infarction (56) . Many candidate biomarkers of AKI have been identified (Table 6) (57, 58) . Serum cystatin C levels show high correlation to established AKI and are used by some urologists as a marker of disease progression after kidney transplantation (59) . Kidney injury molecule-1, interleukin-18, and liver fatty acid-binding protein have been shown to be associated with kidney ischemia (60, 61) . Clinical studies indicate urine and serum neutrophil gelatinase-associated li- Figure 1 . Degradation in oxygen tension through renal cortex and medulla (22) . The cortex has an ample blood supply and is generally well-oxygenated. The medullary ray areas are devoid of glomeruli and are supplied by venous blood ascending from the medulla. The medulla has a low blood supply and is poorly oxygenated but is responsible for concentration of the urine. Medullary hypoxia results from the countercurrent exchange of oxygen within the vasa recta and from the consumption of oxygen by the medullary thick ascending limbs. Renal medullary hypoxia is an obligatory part of the process of urinary concentration. Reproduced with permission from Brezis and Rosen (22) . pocalin as highly sensitive, specific, and predictive of AKI in many different disease processes (62, 63) . A recent meta-analysis demonstrated high neutrophil gelatinase-associated lipocalin sensitivity in AKI for a value of serum neutrophil gelatinase-associated lipocalin Ͼ150 ng/mL (64) . In pediatrics, neutrophil gelatinase-associated lipocalin has been studied after CPB, after nephrotoxin administration and contrast nephropathy, in sepsis, and in cardiorenal syndrome. Urine neutrophil gelatinase-associated lipocalin concentrations Ͼ50 g/mL predict AKI in children after CPB with high sensitivity and specificity (62) . Diagnostic Adjuncts. Other real-time modalities are being tested for AKI diagnosis. Minute-to-minute variations in somatic nearinfrared spectroscopy numbers may be correlative with low perfusion states, including pediatric emergency department patients with hypovolemia (65, 66) . Imaging modalities such as blood oxygen level-dependent magnetic resonance imaging have been used in adults to determine changes in renal parenchymal oxygenation (67) . Adult urine PO 2 levels, assumed to mirror changes in renal oxygenation, have been correlated to AKI (68) .
AKI is clearly a major contributor to overall morbidity and mortality in hospitalized patients. Although stratification strata continue to advance as epidemiologic tools, biomarker research seeks to deliver intensivists real-time and sensitive tests of even subtle kidney injury, injury that may have more consequences than simply signaling the kidney's own death knell. Reported incidence of acute kidney injury in select pediatric studies.
Management
Development of management parameters in AKI is limited by the multifactorial etiology of the disease process and by the paucity of prospectively validated data. Thus, although universally based on limiting future injury, patient management is quite heterogeneous.
Maintaining Renal Perfusion. To limit ischemic injury, attempts are made to modulate renal perfusion pressure and to optimize renal preload. The use of renal vasodilators to increase renal perfusion has not demonstrated improved outcomes. Adult studies of low-dose, or "renal-dose," dopamine have failed to show benefit and actually may even be harmful (69, 70) . Low-dose dopamine in children has not been effective at improving outcomes either (6, 71) . Fenoldopam, a selective dopamine agonist, increases renal blood flow and may reduce mortality and the need for renal replacement therapy (RRT) in adults (72) but has not significantly improved AKI outcomes in children (73, 74) .
No consensus exists regarding the appropriate balance of fluids, diuresis, and dialysis to use in AKI. In response to hypoperfusion, many patients may receive total fluid doses to reach central venous pressure and mean arterial pressure targets that result in total body water overload (75, 76) . Intravenous fluids are medicines prescribed and administered like all other drugs, and warning signs of "overdose" should be heeded before every dose. A study of Ͼ3,000 adult patients revealed a link between positive fluid balance and mortality in AKI (77) . The Prospective Pediatric Continuous Renal Replacement Therapy Registry Group (Prospective Pediatric CRRT), studying a sample of 116 children, retrospectively found increased fluid administration to be independently associated with mortality in children started on CRRT (78) .
Crystalloid or Colloid Infusions. In the adult population, studies have compared albumin to saline (SAFE study [79] ) and hydroxyethyl starches to saline (SOAP study [80] ) for resuscitation. Neither demonstrated clear benefit in colloid over crystalloid infusions. There was no survival difference in Ͼ7,000 patients between recipients of albumin or saline (SAFE). Conflicting correlations between AKI and the use of starches for resuscitation during sepsis have been reported. There have been no published studies relating type of fluid used in pediatric resuscitation and AKI incidence or outcomes.
Diuretics. Reducing fluid overload with diuresis can limit the use of renal replacement therapy but has not been proven to improve outcomes of AKI.
Adults. The use of diuretics in adults with AKI has been associated with an increased risk of death and has shown no benefit in recovery of kidney function (81, 82) . There is also no evidence of a mortality benefit in using diuretics to convert oliguric AKI into nonoliguric AKI. Several trials involving recombinant atrial natriuretic peptide have shown conflicting results.
Pediatrics. Data regarding augmentation of urine output in pediatric AKI using diuretics are limited to bone marrow transplantation and after bypass (74, 83) . The use of natriuretic peptides has been attempted in patients with AKI and cardiorenal syndrome (84) . Brain natriuretic peptide (nesiritide), described in children with decompensated heart failure, increases diuresis but its effect on isolated AKI is not known (85) .
Continuous RRT. Other than emergent dialytic therapy for electrolyte disturbance or ingested toxins, controversies abound with regard to the proper timing of initiation, dose, route, and duration of continuous RRT (CRRT) in AKI. Prospective adult data based on blood urea nitrogen value cutoffs are heterogeneous for timing of initiation and outcome. The mortality for adults started on CRRT is nearly 60% in some studies (86 -88) . In pediatrics, the percent fluid overload has been used as an initiating trigger and is calculated as follows: fluid overload ϭ [(⌺ fluid IN Ϫ ⌺ fluid-OUT )/admission weight] ϫ 100.
Retrospective study of 21 children receiving CRRT for AKI suggested that the degree of fluid overload at time of CRRT initiation was significantly lower in survivors than in nonsurvivors (16.4% vs. 34%) (89) . In a larger study of 113 children with multiple organ dysfunction syndrome started on CRRT, median percent fluid overload was significantly lower in survivors compared to nonsurvivors (7.8% vs. 15.1%), independent of severity of illness (90) . Even more recently, in 297 patients, percent fluid overload was again significantly lower in survivors vs. nonsurvivors (12.5% vs. 23.0%) (91) . DiCarlo (92) initiated CRRT for ten children with acute respiratory distress syndrome after bone marrow transplantation regardless of presence of AKI in a prospective observational study, with an 80% survival rate. The mortality for children started on CRRT is 10% to 57.1% (Table 7) . Although Prospective Pediatric CRRT data suggest that 10% to 15% fluid overload is the signal for CRRT or peritoneal dialysis initiation, this has yet to be prospectively proven. Further, it has yet to be demonstrated that children administered CRRT for AKI have better outcomes than those without such therapy.
RRT Dose and Modality. A large recent study with meticulous documentation of actual doses received demonstrated no improvement in kidney function or mortality outcome in adults receiving high-intensity CRRT (35 mL/kg/hr) vs. low-intensity CRRT (20 mL/kg/ hr) or intermittent hemodialysis (87) . The few outcomes studies performed in pediatrics investigating the effects of RRT dosage and modality are retrospective. The Prospective Pediatric CRRT in 2007 demonstrated no difference in overall outcomes based on modality or dose of CRRT used (93) . Although another study showed some improvement in outcome using convective CRRT modes for bone marrow transplantation patients, many centers only offer one mode of CRRT delivery, and thus study applicability is limited.
Peritoneal Dialysis. Peritoneal dialysis can be efficacious in fluid overload and offers advantages for younger children, including simplicity, less invasiveness, and improved hemodynamic tolerance (94) . Peritoneal dialysis is generally safe and effective in children after CPB, with some investigators utilizing it as a prophylactic therapy as well (95) .
CRRT for Immunomodulation. CRRT has been used in septic adults with the intention of altering levels of circulating cytokines and inflammatory mediators (96, 97) . Modifications of High-performing biomarkers for acute kidney injury based on performance in high-quality individual trials in which outcome measure was either sensitivity or specificity of the test (Ͼ0.75), area under the receiver-operating characteristic curve (Ͼ0.75), or likelihood ratio (Ͼ2). Adapted with permission from Parikh et al (58) .
CRRT have not improved outcomes for such patients. To date, literature does not support the use of CRRT for sepsis without AKI.
In summary, few prospectively validated data exist regarding the effect of CRRT on outcomes. Although some data suggest that early and aggressive CRRT initiation may be beneficial in children with fluid overload, the questions that need to be objectively addressed are the definitions of "early" and "aggressive." We as practitioners must continually weigh the inherent risks associated with initiating RRT, including placement of large venous catheters and creating significant hemodynamic and thermal shifts in children with unstable conditions, against the possible benefits, which, to this point, have been only retrospectively demonstrated.
Oxidative and Inflammatory Homeostasis.
The kidney has derangements in oxygen homeostasis during AKI. Although prospective study of CPB patients demonstrated that anemia is independently associated with AKI, the risks of increased volume and blood viscosity must be balanced against the presumed benefit of increased oxygen-carrying capacity. Studies of N-acetylcysteine and dexamethasone therapies to limit oxidative and inflammatory damage in AKI after CPB showed conflicting results (98 -101) . The use of nephrotoxins such as aminoglycoside antimicrobials, nonsteroidal anti-inflammatory drugs, radiocontrast media, antifungal agents, and immunosuppressive drugs are associated with high rates of AKI and must be diligently constrained (102) .
Nutritional Support. Nutrition in adult AKI is important and minding macronutrient and micronutrient requirements is vital to outcome (50) . Optimizing nutrition in pediatric AKI patients can be challenging, and Bunchman (10) recommends using a metabolic cart to determine the amount of nutrition necessary. CRRT may reduce fluid concerns when optimal nutrition, using renoprotective and anabolic formulas, is desired. Recent large, prospective, randomized, control trials suggest that tight glucose control increases overall mortality and also show no difference in the number of adult patients requiring RRT based on glycemic control strategy (103) . A prospective pediatric study demonstrated morbidity improvements in children receiving intensive insulin therapy, CV, cardiogenic; BMT, bone marrow transplantation; FO, fluid overload at time of initiation. Reported mortality in renal replacement therapy in select pediatric studies.
but no effects on outcomes with AKI or dialysis were seen (104) .
CONCLUSIONS
The management of AKI in pediatrics is complex and challenging. Our understanding and ability to detect renal distress and its possible autocrine and endocrine effects are in their infancy. Biomarkers may improve our management if early detection actually affects outcomes. To date, therapy of AKI revolves around optimizing renal perfusion pressure and oxygenation through a combination of judicious fluid prescription, inotropy, and RRT while attending to proper nutrition and avoidance of additional nephrotoxins. However, pediatric intensivists have limited consensus or best-practice parameters to follow, as little prospective evidence is available. Kidney injury is likely incremental, more temporally proximal than fluid overload and anuric failure, and likely causes more significant distal harm than previously appreciated. The impact of AKI on critically ill children is significant and demands prospective study if we are to find effective therapies and improve outcomes.
